Przegląd Dermatologiczny

Full text

2/2026 vol. 113
Review article

Current and Emerging Approaches to Androgenetic Alopecia

Aleksandra Z. Bilińska 1
,
Adrian Gutowski 2
,
Klaudia Szatanik 2

  1. University Clinical Hospital No. 2 of the Medical University of Lodz, Poland

  2. Norbert Barlicki University Clinical Hospital No. 1 of the Medical University of Lodz, Poland

Dermatol Rev/Przegl Dermatol 2026, 113, 74–81

DOI: https://doi.org/10.5114/dr.2026.163247
Data publikacji online: 2026/07/31
Article file
Current and Emerging.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Lolli F., Pallotti F., Rossi A., Fortuna M.C., Caro G., Lenzi A., et al.: Androgenetic alopecia: a review. Endocrine 2017, 57, 9-17.
  2. Vañó-Galván S., Saceda-Corralo D., Blume-Peytavi U., Cucchía J., Dlova N.C., Gavazzoni Dias M.F., et al.: Frequency of the types of alopecia at twenty-two specialist hair clinics: a multicenter study. Skin Appendage Disord 2019, 5, 309-315.
  3. Aukerman E.L., Jafferany M.: The psychological consequences of androgenetic alopecia: a systematic review. J Cosmet Dermatol 2022, 21, 3723-3730.
  4. Ong M.M., Li Y., Lipner S.R.: Oral minoxidil for alopecia treatment: risks, benefits, and recommendations. Am J Clin Dermatol 2025, 27, 101-119.
  5. Rathnayake D., Sinclair R.: Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Dermatol Clin 2010, 28, 611-618.
  6. Ntshingila S., Oputu O., Arowolo A.T., Khumalo N.P.: Androgenetic alopecia: an update. JAAD Int 2023, 13, 150-158.
  7. Kasumagic-Halilovic E.: Trichoscopic findings in androgenetic alopecia. Med Arch 2021, 75, 109-111.
  8. Stefanato C.M.: Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology 2010, 56, 24-38.
  9. Gordon K.A., Tosti A.: Alopecia: evaluation and treatment. Clin Cosmet Investig Dermatol 2011, 4, 101-106.
  10. Katzer T., Leite Junior A., Beck R., da Silva C.: Physiopathology and current treatments of androgenetic alopecia: going beyond androgens and anti-androgens. Dermatol Ther 2019, 32, e13059.
  11. Ellis J.A., Harrap S.B.: The genetics of androgenetic alopecia. Clin Dermatol 2001, 19, 149-154.
  12. Zhang J., Wu Y., Wang F.: The association between alcohol consumption and the severity of male androgenic alopecia in Chinese participants: a single-center cross-sectional study. J Am Acad Dermatol 2025, 92, 175-177.
  13. Fortes C., Mastroeni S., Mannooranparampil T.J., Ribuffo M.: The combination of overweight and smoking increases the severity of androgenetic alopecia. Int J Dermatol 2017, 56, 862-867.
  14. Liu L.P., Wariboko M.A., Hu X., Wang Z.H., Wu Q., Li Y.M.: Factors associated with early-onset androgenetic alopecia: a scoping review. PLoS One 2024, 19, e0299212.
  15. Cousen P., Messenger A.: Female pattern hair loss in complete androgen insensitivity syndrome. Br J Dermatol 2010, 162, 1135-1137.
  16. Starace M., Orlando G., Alessandrini A., Piraccini B.M.: Female androgenetic alopecia: an update on diagnosis and management. Am J Clin Dermatol 2020, 21, 69-84.
  17. Jiang Y., Shi Q., Huang Y., Li J., Xie H., Liu F.: Relationship between exercise and severity of androgenic alopecia. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2021, 46, 725-730.
  18. Gupta A.K., Talukder M., Keene S.A., Bamimore M.A.: Is the safety of finasteride correlated with its route of administration: topical versus oral? A pharmacovigilance study with data from the United States Food and Drug Administration Adverse Event Reporting System. Int J Dermatol 2025, 65, 108-118.
  19. Devjani S., Ezemma O., Kelley K.J., Stratton E., Senna M.: Androgenetic alopecia: therapy update. Drugs 2023, 83, 701-715.
  20. Jia L., Xiong J., Guo R., Li Y., Jiang H.: A comprehensive review of microneedling as a potential treatment option for androgenetic alopecia. Aesthetic Plast Surg 2022, 46, 2979-2994.
  21. Anitua E., Tierno R., Alkhraisat M.H.: Platelet-rich plasma in the management of alopecia: a systematic review and meta-analysis of clinical evidence. Dermatol Ther 2025, 15, 3213-3252.
  22. Linas S.L., Nies A.S.: Minoxidil. Ann Intern Med 1981, 94, 61-65.
  23. Blume-Peytavi U., Hillmann K., Dietz E., Canfield D., Garcia Bartels N.: A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol 2011, 65, 1126-1134.e2.
  24. Messenger A.G., Rundegren J.: Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004, 150, 186-194.
  25. Bi L., Kan H., Wang J., Ding Y., Huang Y., Wang C., et al.: Whether the transient hair shedding phase exists after minoxidil treatment and does it predict treatment efficacy? A retrospective study in androgenetic alopecia patients. J Dermatolog Treat 2025, 36, e2480739.
  26. Goren A., Shapiro J., Roberts J., McCoy J., Desai N., Zarrab Z., et al.: Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatol Ther 2015, 28, 13-16.
  27. Shadi Z.: Compliance to topical minoxidil and reasons for discontinuation among patients with androgenetic alopecia. Dermatol Ther 2023, 13, 1157-1169.
  28. Ebner H., Müller E.: Allergic contact dermatitis from minoxidil. Contact Dermatitis 1995, 32, 316-317.
  29. Nestor M.S., Ablon G., Gade A., Han H., Fischer D.L.: Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol 2021, 20, 3759-3781.
  30. Olsen E.A., Whiting D., Bergfeld W., Miller J., Hordinsky M., Wanser R., et al.: A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2007, 57, 767-774.
  31. Penha M.A., Miot H.A., Kasprzak M., Ramos P.M.: Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatol 2024, 160, 600-605.
  32. Shapiro J., Kaufman K.D.: Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Investig Dermatol Symp Proc 2003, 8, 20-23.
  33. Clark R.V., Hermann D.J., Cunningham G.R., Wilson T.H., Morrill B.B., Hobbs S.: Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor. J Clin Endocrinol Metab 2004, 89, 2179-2184.
  34. Van Neste D., Fuh V., Sanchez-Pedreno P., Lopez-Bran E., Wolff H., Whiting D., et al.: Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol 2000, 143, 804-810.
  35. Kaufman K.D., Olsen E.A., Whiting D., Savin R., DeVillez R., Bergfeld W., et al.: Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998, 39, 578-589.
  36. Brzezińska-Wcisło L., Rakowska A., Rudnicka L., Bergler-Czop B., Czuwara J., Maj J., et al.: Androgenetic alopecia: diagnostic and therapeutic recommendations of the Polish Dermatological Society. Dermatol Rev 2018, 105, 1-18.
  37. BinJadeed H.F., Alajlan A.: Pregnancy and neonatal outcome with maternal exposure to finasteride: case series. J Dermatol Dermatol Surg 2021, 25, 84-86.
  38. Escamilla-Cruz M., Magaña M., Escandón-Perez S., Bello-Chavolla O.Y.: Use of 5-alpha reductase inhibitors in dermatology: a narrative review. Dermatol Ther 2023, 13, 1721-1731.
  39. Santana F.F.V., Lozi A.A., Gonçalves R.V., Da Silva J., Pinto Da Matta S.L.: Comparative effects of finasteride and minoxidil on the male reproductive organs: a systematic review of in vitro and in vivo evidence. Toxicol Appl Pharmacol 2023, 478, 116710.
  40. Traish A.M.: Post-finasteride syndrome: a surmountable challenge for clinicians. Fertil Steril 2020, 113, 21-50.
  41. Gupta A.K., Talukder M., Williams G.: Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. J Dermatolog Treat 2022, 33, 2946-2962.
  42. Giatti S., Di Domizio A., Diviccaro S., Falvo E., Caruso D., Contini A., et al.: Three-dimensional proteome-wide scale screening for the 5-alpha reductase inhibitor finasteride: identification of a novel off-target. J Med Chem 2021, 64, 4553-4566.
  43. Caserini M., Radicioni M., Leuratti C., Annoni O., Palmieri R.: A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. Int J Clin Pharmacol Ther 2014, 52, 842-849.
  44. Piraccini B.M., Blume-Peytavi U., Scarci F., Jansat J.M., Falqués M., et al.: Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol 2021, 36, 286-294.
  45. Gupta A.K., Talukder M.: Topical finasteride for male and female pattern hair loss: is it a safe and effective alternative? J Cosmet Dermatol 2022, 21, 1841-1848.
  46. Perper M., Aldahan A.S., Fayne R.A., Emerson C.P., Nouri K.: Efficacy of fractional lasers in treating alopecia: a literature review. Lasers Med Sci 2017, 32, 1919-1925.
  47. Pillai J.K., Mysore V.: Role of low-level light therapy in androgenetic alopecia. J Cutan Aesthet Surg 2021, 14, 385-391.
  48. Leavitt M., Charles G., Heyman E., Michaels D.: HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicenter trial. Clin Drug Investig 2009, 29, 283-292.
  49. Esmat S.M., Hegazy R.A., Gawdat H.I., Abdel Hay R.M., Allam R.S., El Naggar R., et al.: Low-level light-minoxidil 5% combination versus either therapeutic modality alone in management of female pattern hair loss: a randomized controlled study. Lasers Surg Med 2017, 49, 835-843.
  50. Egger A., Resnik S.R., Aickara D., Maranda E., Kaiser M., Wikramanayake T.C., et al.: Examining the safety and efficacy of low-level laser therapy for male and female pattern hair loss: a review of the literature. Skin Appendage Disord 2020, 6, 259-267.
  51. Shiell R.C.: A review of modern surgical hair restoration techniques. J Cutan Aesthet Surg 2008, 1, 12-16.
  52. Bater K.L., Ishii M., Joseph A., Su P., Nellis J., Ishii L.E.: Perception of hair transplant for androgenetic alopecia. JAMA Facial Plast Surg 2016, 18, 413-418.
  53. Avram M.R., Watkins S.: Robotic hair transplantation. Facial Plast Surg Clin North Am 2020, 28, 189-196.
  54. Liu R.H., Xu L.J., McCarty J.C., Xiao R., Chen J.X., Lee L.N.: A scoping review on complications in modern hair transplantation: more than just splitting hairs. Aesthetic Plast Surg 2025, 49, 585-595.
  55. Burns L.J., De Souza B., Flynn E., Hagigeorges D., Senna M.M.: Spironolactone for treatment of female pattern hair loss. J Am Acad Dermatol 2020, 83, 276-278.
  56. James J.F., Jamerson T.A., Aguh C.: Efficacy and safety profile of oral spironolactone use for androgenic alopecia: a systematic review. J Am Acad Dermatol 2022, 86, 425-429.
  57. Choi G.S., Sim W.Y., Kang H., Huh C.H., Lee Y.W., Shantakumar S., et al.: Long-term effectiveness and safety of dutasteride versus finasteride in patients with male androgenic alopecia in South Korea: a multicenter chart review study. Ann Dermatol 2022, 34, 349-359.
  58. Zhou Z., Song S., Gao Z., Wu J., Ma J., Cui Y.: The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clin Interv Aging 2019, 14, 399-406.
  59. Ding Y., Wang C., Bi L., Du Y., Lu C., Zhao M., et al.: Dutasteride for the treatment of androgenetic alopecia: an updated review. Dermatology 2024, 240, 833-843.
  60. Asim M., Shah R., Sharif S., Ouellette S., Shah A., Rao B.: A randomized controlled trial comparing the efficacy of platelet-rich plasma and 5% topical minoxidil for the treatment of androgenetic alopecia. J Drugs Dermatol 2023, 22, 905-909.
  61. Yoon S.K., Kwan H.J., Jung E.K., Young W.J., Beom J.K., Hoon K.: Repeated microneedle stimulation induces enhanced hair growth in a murine model. Ann Dermatol 2016, 28, 586-592.
  62. Gupta A.K., Quinlan E.M., Venkataraman M., Bamimore M.A.: Microneedling for hair loss. J Cosmet Dermatol 2022, 21, 108-117.
  63. Choi M.S., Park B.C.: The efficacy and safety of the combination of photobiomodulation therapy and pulsed electromagnetic field therapy on androgenetic alopecia. J Cosmet Dermatol 2023, 22, 831-836.
  64. Lama S.B.C., Pérez-González L.A., Kosoglu M.A., Dennis R., Ortega-Quijano D.: Physical treatments and therapies for androgenetic alopecia. J Clin Med 2024, 13, 4534.
  65. Johnson H., Huang D., Clift A.K., Bersch-Ferreira Â., Guimarães G.A.: Effectiveness of combined oral minoxidil and finasteride in male androgenetic alopecia: a retrospective service evaluation. Cureus 2025, 17, e77549.
  66. Dhurat R., Sukesh M., Avhad G., Dandale A., Pal A., Pund P.: A randomized evaluator-blinded study of the effect of microneedling in androgenetic alopecia: a pilot study. Int J Trichology 2013, 5, 6-11.
  67. Yu L., Moorthy S., Li X., Peng L., Zhang Z., Shen L., et al.: Assessing the efficacy and quality-of-life improvements of botulinum toxin type A with topical minoxidil versus topical minoxidil in male androgenetic alopecia: a randomized controlled trial. Arch Dermatol Res 2024, 316, 532.
  68. Xiao C., Zhang G.H., Li H.Q., Yang P.P., Zhang H.B., Mu Y.X.: Meta-analysis of efficacy of platelet-rich plasma combined with minoxidil for androgenetic alopecia. Aesthetic Plast Surg 2024, 48, 4554-4566.
Copyright: © 2026 Polish Dermatological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Indeks osobowy
Share
without publication fees
without publication fees
Coverage in
Integrated with
plagiat pl
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications